AOCNP (Advanced Oncology Certified Nurse
Practitioner) WITH CORRECT ACTUAL
QUESTIONS AND CORRECTLY WELL DEFINED
ANSWERS LATEST ALREADY GRADED A+
(2026/2027)
Question 1
Which lifestyle modification is most strongly associated with a reduced risk of
developing colorectal cancer?
A. High-dose vitamin E supplementation
B. Daily consumption of processed red meat
C. Regular physical activity of ≥150 minutes per week
D. Exclusive use of fruit juice for hydration
Correct Answer: C. Regular physical activity of ≥150 minutes per week
Rationale: Regular moderate-intensity physical activity lowers colorectal cancer risk by
improving bowel motility and reducing insulin resistance. Processed red meat increases
risk, and vitamin E supplementation has no proven benefit .
Question 2
A 45-year-old woman with a family history of early-onset breast cancer requests
genetic testing. Which gene mutation should be prioritized for testing?
A. BRCA1
B. KRAS
C. EGFR
D. BCR-ABL
Correct Answer: A. BRCA1
,Rationale: BRCA1 and BRCA2 mutations confer high hereditary breast and ovarian
cancer risk, especially with early-onset family history. KRAS, EGFR, and BCR-ABL are
somatic oncogenes, not primary hereditary markers .
Question 3
A 58-year-old patient with newly diagnosed non-small cell lung cancer asks about
PD-L1 testing. The AOCNP explains that PD-L1 testing primarily guides:
A. Surgical candidacy
B. Radiation dosing
C. Immunotherapy selection
D. Chemotherapy toxicity prediction
Correct Answer: C. Immunotherapy selection
Rationale: PD-L1 expression on tumor cells predicts response to immune checkpoint
inhibitors like pembrolizumab, making it a critical biomarker for immunotherapy
selection .
Question 4
When assessing performance status in an adult oncology patient, which scale
assigns a score of 0 to a fully active individual?
A. ECOG
B. Karnofsky
C. WHO
D. APACHE II
Correct Answer: A. ECOG
Rationale: The ECOG Performance Status Scale ranges from 0 (fully active) to 5 (dead),
assessing functional ability and influencing treatment decisions. Karnofsky ranges from 0
(dead) to 100 (normal) .
Question 5
,In the TNM staging system for non-small cell lung cancer, what does "N2"
specifically indicate?
A. Tumor invades the visceral pleura
B. No regional lymph node metastasis
C. Metastasis to ipsilateral mediastinal or subcarinal lymph nodes
D. Distant metastasis
Correct Answer: C. Metastasis to ipsilateral mediastinal or subcarinal lymph nodes
Rationale: N2 denotes metastasis to ipsilateral mediastinal or subcarinal lymph nodes.
N0 indicates no nodal involvement, T describes tumor size/extent, and M indicates
distant spread .
Question 6
A patient with a 30-pack-year smoking history, currently smoking, is 58 years old.
Which screening is recommended by NCCN guidelines?
A. Chest X-ray annually
B. Low-dose CT chest annually
C. Sputum cytology every 6 months
D. PET/CT every 3 years
Correct Answer: B. Low-dose CT chest annually
Rationale: NCCN recommends annual low-dose CT for adults aged 55-80 with ≥30
pack-year history who currently smoke or have quit within 15 years .
Question 7
Which biomarker is predictive for response to trastuzumab in HER2-positive breast
cancer?
A. CA-125
B. HER2 overexpression
C. KRAS mutation
D. PD-L1 expression
, Correct Answer: B. HER2 overexpression
Rationale: HER2 overexpression is a predictive biomarker for trastuzumab response.
CA-125 monitors ovarian cancer, KRAS predicts EGFR inhibitor resistance in colorectal
cancer, and PD-L1 guides immunotherapy .
Question 8
BRCA1 mutation increases risk primarily for which cancers?
A. Thyroid and colon cancer
B. Breast and ovarian cancer
C. Colon and lung cancer
D. Lung and prostate cancer
Correct Answer: B. Breast and ovarian cancer
Rationale: BRCA1 and BRCA2 are tumor suppressor genes; pathogenic mutations confer
significantly increased lifetime risks for breast, ovarian, and other cancers .
Question 9
Sentinel lymph node biopsy is most relevant in which malignancy?
A. Leukemia
B. Early-stage breast cancer
C. Multiple myeloma
D. Brain tumors
Correct Answer: B. Early-stage breast cancer
Rationale: Sentinel lymph node biopsy is a standard surgical staging procedure for
early-stage breast cancer to determine nodal involvement without complete axillary
dissection .
Question 10
Practitioner) WITH CORRECT ACTUAL
QUESTIONS AND CORRECTLY WELL DEFINED
ANSWERS LATEST ALREADY GRADED A+
(2026/2027)
Question 1
Which lifestyle modification is most strongly associated with a reduced risk of
developing colorectal cancer?
A. High-dose vitamin E supplementation
B. Daily consumption of processed red meat
C. Regular physical activity of ≥150 minutes per week
D. Exclusive use of fruit juice for hydration
Correct Answer: C. Regular physical activity of ≥150 minutes per week
Rationale: Regular moderate-intensity physical activity lowers colorectal cancer risk by
improving bowel motility and reducing insulin resistance. Processed red meat increases
risk, and vitamin E supplementation has no proven benefit .
Question 2
A 45-year-old woman with a family history of early-onset breast cancer requests
genetic testing. Which gene mutation should be prioritized for testing?
A. BRCA1
B. KRAS
C. EGFR
D. BCR-ABL
Correct Answer: A. BRCA1
,Rationale: BRCA1 and BRCA2 mutations confer high hereditary breast and ovarian
cancer risk, especially with early-onset family history. KRAS, EGFR, and BCR-ABL are
somatic oncogenes, not primary hereditary markers .
Question 3
A 58-year-old patient with newly diagnosed non-small cell lung cancer asks about
PD-L1 testing. The AOCNP explains that PD-L1 testing primarily guides:
A. Surgical candidacy
B. Radiation dosing
C. Immunotherapy selection
D. Chemotherapy toxicity prediction
Correct Answer: C. Immunotherapy selection
Rationale: PD-L1 expression on tumor cells predicts response to immune checkpoint
inhibitors like pembrolizumab, making it a critical biomarker for immunotherapy
selection .
Question 4
When assessing performance status in an adult oncology patient, which scale
assigns a score of 0 to a fully active individual?
A. ECOG
B. Karnofsky
C. WHO
D. APACHE II
Correct Answer: A. ECOG
Rationale: The ECOG Performance Status Scale ranges from 0 (fully active) to 5 (dead),
assessing functional ability and influencing treatment decisions. Karnofsky ranges from 0
(dead) to 100 (normal) .
Question 5
,In the TNM staging system for non-small cell lung cancer, what does "N2"
specifically indicate?
A. Tumor invades the visceral pleura
B. No regional lymph node metastasis
C. Metastasis to ipsilateral mediastinal or subcarinal lymph nodes
D. Distant metastasis
Correct Answer: C. Metastasis to ipsilateral mediastinal or subcarinal lymph nodes
Rationale: N2 denotes metastasis to ipsilateral mediastinal or subcarinal lymph nodes.
N0 indicates no nodal involvement, T describes tumor size/extent, and M indicates
distant spread .
Question 6
A patient with a 30-pack-year smoking history, currently smoking, is 58 years old.
Which screening is recommended by NCCN guidelines?
A. Chest X-ray annually
B. Low-dose CT chest annually
C. Sputum cytology every 6 months
D. PET/CT every 3 years
Correct Answer: B. Low-dose CT chest annually
Rationale: NCCN recommends annual low-dose CT for adults aged 55-80 with ≥30
pack-year history who currently smoke or have quit within 15 years .
Question 7
Which biomarker is predictive for response to trastuzumab in HER2-positive breast
cancer?
A. CA-125
B. HER2 overexpression
C. KRAS mutation
D. PD-L1 expression
, Correct Answer: B. HER2 overexpression
Rationale: HER2 overexpression is a predictive biomarker for trastuzumab response.
CA-125 monitors ovarian cancer, KRAS predicts EGFR inhibitor resistance in colorectal
cancer, and PD-L1 guides immunotherapy .
Question 8
BRCA1 mutation increases risk primarily for which cancers?
A. Thyroid and colon cancer
B. Breast and ovarian cancer
C. Colon and lung cancer
D. Lung and prostate cancer
Correct Answer: B. Breast and ovarian cancer
Rationale: BRCA1 and BRCA2 are tumor suppressor genes; pathogenic mutations confer
significantly increased lifetime risks for breast, ovarian, and other cancers .
Question 9
Sentinel lymph node biopsy is most relevant in which malignancy?
A. Leukemia
B. Early-stage breast cancer
C. Multiple myeloma
D. Brain tumors
Correct Answer: B. Early-stage breast cancer
Rationale: Sentinel lymph node biopsy is a standard surgical staging procedure for
early-stage breast cancer to determine nodal involvement without complete axillary
dissection .
Question 10
